ID CDKN3_PIG Reviewed; 212 AA. AC Q9MYN5; DT 10-AUG-2010, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2000, sequence version 1. DT 27-MAR-2024, entry version 98. DE RecName: Full=Cyclin-dependent kinase inhibitor 3 {ECO:0000250|UniProtKB:Q16667, ECO:0000303|PubMed:12078753, ECO:0000312|EMBL:CAB98135.1}; DE EC=3.1.3.16; DE EC=3.1.3.48; DE AltName: Full=CDK2-associated dual-specificity phosphatase {ECO:0000250|UniProtKB:Q16667, ECO:0000303|PubMed:12078753}; DE AltName: Full=Kinase-associated phosphatase {ECO:0000250|UniProtKB:Q16667}; GN Name=CDKN3 {ECO:0000312|EMBL:CAB98135.1}; GN Synonyms=KAP {ECO:0000250|UniProtKB:Q16667}; OS Sus scrofa (Pig). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus. OX NCBI_TaxID=9823; RN [1] {ECO:0000312|EMBL:CAB97522.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. RC TISSUE=Thigh muscle {ECO:0000269|PubMed:12078753}; RX PubMed=12078753; DOI=10.2527/2002.8061698x; RA Maak S., Jaesert S., Neumann K., von Lengerken G.; RT "Rapid communication: nucleotide sequence and physical mapping of the RT porcine cyclin-dependent kinase inhibitor 3 (CDKN3) gene."; RL J. Anim. Sci. 80:1698-1699(2002). RN [2] {ECO:0000305} RP VARIANTS VAL-6; CYS-39; PHE-60; CYS-76; SER-78 AND GLY-79. RX PubMed=12927088; DOI=10.1186/1297-9686-35-s1-s157; RA Maak S., Jaesert S., Neumann K., von Lengerken G.; RT "Characterization of the porcine CDKN3 gene as a potential candidate for RT congenital splay leg in piglets."; RL Genet. Sel. Evol. 35:S157-S165(2003). CC -!- FUNCTION: May play a role in cell cycle regulation. Dual specificity CC phosphatase active toward substrates containing either phosphotyrosine CC or phosphoserine residues. Dephosphorylates CDK2 at 'Thr-160' in a CC cyclin-dependent manner (By similarity). CC {ECO:0000250|UniProtKB:Q16667}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] + CC phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA- CC COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858, CC ChEBI:CHEBI:82620; EC=3.1.3.48; CC Evidence={ECO:0000250|UniProtKB:Q16667}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] + CC phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA- CC COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:83421; EC=3.1.3.16; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] + CC phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA- CC COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:61977; EC=3.1.3.16; CC -!- SUBUNIT: Interacts with cyclin-dependent kinases such as CDK1, CDK2 and CC CDK3. Does not interact with CDK4. Interacts (via C-terminus) with CC phosphorylated CDK2 (via C-terminal helix). Interacts with MS4A3 (via CC C-terminus); the interaction enhances CDKN3 enzymatic activity (By CC similarity). {ECO:0000250|UniProtKB:Q16667}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region CC {ECO:0000250|UniProtKB:Q16667}. CC -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. CC {ECO:0000255}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ404882; CAB97522.1; -; mRNA. DR EMBL; AJ404883; CAB98135.1; -; Genomic_DNA. DR EMBL; AJ404884; CAB98135.1; JOINED; Genomic_DNA. DR RefSeq; NP_999485.1; NM_214320.1. DR RefSeq; XP_013842063.1; XM_013986609.1. DR AlphaFoldDB; Q9MYN5; -. DR SMR; Q9MYN5; -. DR STRING; 9823.ENSSSCP00000060429; -. DR PaxDb; 9823-ENSSSCP00000019951; -. DR GeneID; 397589; -. DR KEGG; ssc:397589; -. DR CTD; 1033; -. DR eggNOG; KOG1720; Eukaryota. DR InParanoid; Q9MYN5; -. DR OrthoDB; 5479521at2759; -. DR PRO; PR:Q9MYN5; -. DR Proteomes; UP000008227; Unplaced. DR Proteomes; UP000314985; Unplaced. DR Proteomes; UP000694570; Unplaced. DR Proteomes; UP000694571; Unplaced. DR Proteomes; UP000694720; Unplaced. DR Proteomes; UP000694722; Unplaced. DR Proteomes; UP000694723; Unplaced. DR Proteomes; UP000694724; Unplaced. DR Proteomes; UP000694725; Unplaced. DR Proteomes; UP000694726; Unplaced. DR Proteomes; UP000694727; Unplaced. DR Proteomes; UP000694728; Unplaced. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB. DR GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC. DR GO; GO:0004725; F:protein tyrosine phosphatase activity; IBA:GO_Central. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0016311; P:dephosphorylation; IEA:InterPro. DR CDD; cd14505; CDKN3-like; 1. DR Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1. DR InterPro; IPR008425; CDK_inhib_3. DR InterPro; IPR022778; CDKN3. DR InterPro; IPR029021; Prot-tyrosine_phosphatase-like. DR InterPro; IPR003595; Tyr_Pase_cat. DR InterPro; IPR000387; Tyr_Pase_dom. DR InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom. DR PANTHER; PTHR23339:SF98; CYCLIN-DEPENDENT KINASE INHIBITOR 3-RELATED; 1. DR PANTHER; PTHR23339; TYROSINE SPECIFIC PROTEIN PHOSPHATASE AND DUAL SPECIFICITY PROTEIN PHOSPHATASE; 1. DR Pfam; PF05706; CDKN3; 1. DR PIRSF; PIRSF037322; CDKN3; 1. DR SMART; SM00404; PTPc_motif; 1. DR SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1. DR PROSITE; PS50056; TYR_PHOSPHATASE_2; 1. DR PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1. PE 2: Evidence at transcript level; KW Cell cycle; Cytoplasm; Hydrolase; Protein phosphatase; Reference proteome. FT CHAIN 1..212 FT /note="Cyclin-dependent kinase inhibitor 3" FT /id="PRO_0000396638" FT DOMAIN 32..201 FT /note="Tyrosine-protein phosphatase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00160" FT REGION 1..34 FT /note="Interaction with CDK2" FT /evidence="ECO:0000250|UniProtKB:Q16667" FT REGION 1..23 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 140 FT /note="Phosphocysteine intermediate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00160" FT VARIANT 6 FT /note="S -> V" FT /evidence="ECO:0000269|PubMed:12927088" FT VARIANT 39 FT /note="Y -> C" FT /evidence="ECO:0000269|PubMed:12927088" FT VARIANT 60 FT /note="I -> F" FT /evidence="ECO:0000269|PubMed:12927088" FT VARIANT 76 FT /note="F -> C" FT /evidence="ECO:0000269|PubMed:12927088" FT VARIANT 78 FT /note="F -> S" FT /evidence="ECO:0000269|PubMed:12927088" FT VARIANT 79 FT /note="C -> G" FT /evidence="ECO:0000269|PubMed:12927088" SQ SEQUENCE 212 AA; 23906 MW; 3AD675A1EA40347E CRC64; MKPPSSIQTS EFDSSDEEPI EDEQTPIQIS WLPLSRVNYS QFLGLCALPG CKFKDVRRNI QKDTEELKSC GIQDVFVFCT RGELSKYRVP NLLDLYHQYG IITHHHPIPD GGAPDIASCC EIMEELEICL QNNRKTLIHC YGGLGRSCLV AACLLLYLSD TVSPQQAIDS LRDLRGSGAI QTIKQYNYLH EFRDKLAAHL SSRESLSRSV SR //